Biolife Sciences Inc BLFE
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.03
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $101.36
- Volume/Avg
- 11.5 Mil / 15.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Core
- Total Number of Employees
- 227
- Website
- https://www.biolifesciences.com
Valuation
|
Metric
|
BLFE
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BLFE
|
|---|---|
Quick Ratio | 0.12 |
Current Ratio | 0.25 |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
|
Metric
|
BLFE
|
|---|---|
Return on Assets (Normalized) | −78.39% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −102.63% |
Return on Assets
No chart available
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Tfy | $110.9 Bil | |
BDX
| Becton Dickinson & Co | Hkhclry | $69.4 Bil | |
ALC
| Alcon Inc | Csrgfbc | $36.1 Bil | |
CLPBY
| Coloplast A/S ADR | Zfns | $26.5 Bil | |
WST
| West Pharmaceutical Services Inc | Crrv | $26.2 Bil | |
RMD
| ResMed Inc | Ltrwd | $22.4 Bil | |
BAX
| Baxter International Inc | Khnmpzk | $18.5 Bil | |
HOLX
| Hologic Inc | Xfggdb | $17.2 Bil | |
COO
| The Cooper Companies Inc | Rmbtl | $16.6 Bil | |
TFX
| Teleflex Inc | Vdcb | $10.3 Bil |